A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/135 (2006.01) A61K 31/137 (2006.01)
Patent
CA 2422901
The present invention is a method of treating a mammal selected from the group consisting of humans and horses who has asthma, COPD or allergic rhinitis and is need of such treatment by inhaling an anti-asthma, anti-COPD anti-allergic rhinitis effective amount, respectively, of a compound selected from the group consisting of tolterodine hydroxytolterodine and 2-(diisopropylamino)ethyl-1- phenylcyclopentanecarboxylate and pharmaceutically acceptable salts thereof.
L'invention concerne un procédé de traitement d'un mammifère choisi dans le groupe constitué par l'homme et le cheval, souffrant d'asthme, de bronchopneumopathie chronique obstructive, ou de rhinite allergique, et dont l'état requiert un tel traitement, ce procédé consistant à inhaler une dose efficace antiasthmatique, anti-bronchopneumopathie chronique obstructive, ou anti-rhinite allergique, respectivement d'un composé choisi dans le groupe constitué par toltérodine représenté par la formule (I)), hydroxytoltérodine, et 2-(diisopropylamino)éthyl-1-phénylcyclopentanecarboxylate, ainsi que des sels de ceux-ci, acceptables sur le plan pharmacologique.
Cammarata Sue K.
Gillberg Per-Goran
Sundquist Staffan
Ab Pharmacia
Macrae & Co.
Pharmacia & Upjohn Company
LandOfFree
Use of tolterodine to treat asthma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tolterodine to treat asthma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tolterodine to treat asthma will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1452235